Company: BGLC
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001477932-25-002725
Chunk: 843

Company: BioNexus Gene Lab Corp
Filing Date: 2025-04-15
Form: 10-K
Item: Item 4
Chunk 843
---
 Li Leong 2024  —   —   —   —   —   —   —   — Former Chief Financial Officer (5) 2023 $16,000                      $842  $16,842 Liong Tai Tan 2024  —   —   —   —   —   —   —   — Chief Operating Officer (6) 2023 $—   —   —   —   —   —   —   — Su-Leng Tan Lee 2024 $490,126  $1,000  $0  $0  $0  $0  $0  $491,126 Chief Executive Officer & Chief Operating Officer (7) 2023 $9,095  $0  $0  $0  $0  $0  $0  $9,095 

(1)Mr. Yeat Min Fong was removed from his position as Chairman of the Company on December 11, 2023.(2)Ms. Yee Meng Wong was removed from her position as President of the Company on December 11, 2023.(3)Mr. Sook Keng Yeoh tendered his resignation to the company on October 4, 2023.(4)Mr. Chi Yuen Leong was appointed as CEO of the Company on October 12, 2023, and removed from his position as CEO of the Company on December 11, 2023.(5)Ms. Wei Li Leong tendered her resignation letter to the Company on October 30, 2023.(6)Mr. Liong Tai Tan tendered his resignation to the Company on August 31, 2023.(7)Mr. Su-Leng Tan Lee began his employment with the Company on September 1, 2023.

 53Table of Contents

Employment Agreements

Employment Agreement between Mr. Su-Leng Tan Lee and the Company

Effective as of August 15, 2023, the Company entered into an employment agreement with Mr. Su-Leng Tan Lee. The agreement provides for an annual base salary. Mr. Tan Lee’s employment will terminate two years from the effective date of the agreement, and such term shall be automatically extended for a one